An Overview on the Development of mRNA-Based Vaccines and Their Formulation Strategies for Improved Antigen Expression In Vivo
The mRNA-based vaccine approach is a promising alternative to traditional vaccines due to its ability for prompt development, high potency, and potential for secure administration and low-cost production. Nonetheless, the application has still been limited by the instability as well as the ineffecti...
Main Authors: | Md. Motiar Rahman, Nan Zhou, Jiandong Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/9/3/244 |
Similar Items
-
mRNA-Based Anti-TCR CDR3 Tumour Vaccine for T-Cell Lymphoma
by: Marina Tusup, et al.
Published: (2021-07-01) -
mRNA vaccine for cancer immunotherapy
by: Lei Miao, et al.
Published: (2021-02-01) -
From COVID-19 to Cancer mRNA Vaccines: Moving From Bench to Clinic in the Vaccine Landscape
by: Chiranjib Chakraborty, et al.
Published: (2021-07-01) -
The Opposing Effect of Type I IFN on the T Cell Response by Non-modified mRNA-Lipoplex Vaccines Is Determined by the Route of Administration
by: Lien Van Hoecke, et al.
Published: (2020-12-01) -
Lipofection with Synthetic mRNA as a Simple Method for T-Cell Immunomonitoring
by: Natalia Teresa Jarzebska, et al.
Published: (2021-06-01)